文献速递临床试验与 GCP流行病学与生物统计

强化同伴PrEP转介联合HIV自检对肯尼亚年轻女性的随机对照试验

Effect of enhanced peer PrEP referral with HIV self-testing delivery among young Kenyan women: A randomized controlled trial of peer networks.
PubMed 文献 · PLoS Med · 2026-03-30

在肯尼亚中部开展整群随机对照试验,将82名16-24岁用过口服PrEP的索引同伴按1:1随机分入强化同伴转介组(培训+发放HIV自检试剂)或标准转介组,评估转介同伴的PrEP启动、续用和HIV检测。结果显示强化转介未提高PrEP启动(30% vs 41%,RD -6%,95%CI -26%~11%,p=0.51),但显著提高近期HIV检测(RD 39%,95%CI 24%~54%,p<0.001),成本约为标准转介的8倍。

要点

  • 强化同伴转介未显著提高PrEP启动率(RD -6%,95%CI -26%~11%,p=0.51)。
  • 强化转介使近期HIV检测率提高39个百分点(95%CI 24%~54%,p<0.001)。
  • 强化转介每位转介至PrEP的同伴成本为23美元,标准转介为3美元。

核心结论

  • 强化同伴PrEP转介联合HIV自检发放未提高肯尼亚AGYW的PrEP启动,但与HIV检测增加相关。

研究设计与样本

  • 在肯尼亚中部开展随机对照试验(NCT04982250),82名16-24岁索引同伴按1:1随机分组,强化组40人、标准组42人。
  • 索引同伴转介241名同伴,强化组137人、标准组104人,3个月后由索引同伴报告结局。

主要发现

  • PrEP启动:强化组30%(41/137) vs 标准组41%(41/104),RD -6%(95%CI -26%~11%),p=0.51。
  • PrEP续用:RD 1%(95%CI -10%~13%),p=0.82,无显著差异。
  • 近期HIV检测:RD 39%(95%CI 24%~54%),p<0.001,强化组显著更高。
  • 强化组3名转介同伴HIV阳性;两组各报告1例言语虐待社会伤害。
  • 强化转介每位转介至PrEP的同伴成本为23美元,标准转介为3美元。

临床怎么用

  • 同伴发放HIV自检试剂可提高AGYW的HIV检测覆盖,但需联合其他策略才能改善PrEP启动。

局限性

  • 依赖索引同伴报告转介同伴的结局是研究局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adolescent girls and young women (AGYW) in Africa experience high HIV acquisition risk and low engagement in prevention services. Knowledge of HIV-negative status paired with peer support might motivate AGYW-who are highly socially connected-to initiate HIV prevention services, including pre-exposure prophylaxis (PrEP). METHODS AND FINDINGS: We conducted a randomized controlled trial (ClinicalTrials.gov: NCT04982250) of AGYW peer networks in Central Kenya. Index peers aged 16-24 years who had used oral PrEP in the past 12 months were randomized 1:1 to: (1) enhanced peer referral: group training on PrEP referral strategies and delivery of HIV self-testing (HIVST) kits (n = 8 kits, 2 kits/peer); or (2) standard peer referral: informal PrEP referral strategies. Index peers were encouraged to refer four peers who could benefit from PrEP. Outcomes for referred peers-PrEP initiation (primary), PrEP continuation (i.e., month one refills), and HIV testing (any form following referral)-were reported by index peers three months later. Implementation outcomes and costs were also assessed. Risk differences (RDs) were estimated using generalized linear mixed-effects regression models with study group fixed effects and index peer random effects. From May 3, 2023 to February 16, 2024, 316 index peers were screened and 82 enrolled/randomized (median age 22 years, IQR 20-23): 40 to the enhanced group and 42 to the standard. No index peers were lost to follow-up. Index peers reported outcomes for 241 referred peers (median age 22 years, IQR 21-24): 137 in the enhanced group and 104 in the standard. At follow-up, there were no significant differences in PrEP initiation between the enhanced group (30%, 41/137) and the standard (41%, 41/104; RD -6%, 95% CI [-26%, 11%], p = 0.51). Enhanced peer referral was not associated with PrEP continuation (RD 1%, 95% CI [-10%, 13%], p = 0.82) but was associated with increased recent HIV testing (RD 39%, 95% CI [24%, 54%], p < 0.001). Three referred peers, all in the enhanced group, tested HIV-positive; two social harms (verbal abuse among index peers, one in each group) were reported. Index and referred peers in both study groups found enhanced peer referral acceptable and feasible, but it cost almost eight times more per peer referred to PrEP than standard referral ($23 versus $3 USD). Relying on index peers to report outcomes for referred peers was a study limitation. CONCLUSIONS: Enhanced peer PrEP referral with training and HIVST delivery did not increase PrEP initiation among Kenyan AGYW but was associated with increased HIV testing, suggesting opportunities to combine peer-delivered HIVST with additional implementation strategies to improve AGYW's PrEP engagement.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Ortblad KF, Wairimu N, Culquichicon C, et al. Effect of enhanced peer PrEP referral with HIV self-testing delivery among young Kenyan women: A randomized controlled trial of peer networks. PLoS Med. 2026. PMID: 41911315. doi:10.1371/journal.pmed.1005023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。